JP Patent

JP6212500B2 — （３ｓ，３ｓ’）４，４’−ジスルファンジイルビス（３−アミノブタン１−スルホン酸）および第２の抗高血圧剤の組合せ

Assigned to Institut National de la Sante et de la Recherche Medicale INSERM · Expires 2017-10-11 · 9y expired

What this patent protects

Patent listed against osilodrostat-phosphate.

Drugs covered by this patent

osilodrostat-phosphate (OSILODROSTAT PHOSPHATE)

Patent Metadata

Patent number: JP6212500B2
Jurisdiction: JP
Classification: —
Expires: 2017-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Institut National de la Sante et de la Recherche Medicale INSERM
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.